The FDA has rejected approval of Apricus’s Vitaros, leaving investors uncertain about the drug’s future.
Apricus Biosciences Inc (NASDAQ:APRI) shares are rising by 3% in Thursday’s trading on the news that Apricus has completed the sale to …
CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are trading up 32% in Wednesday’s trading session after announcing an agreement for healthcare giant Eli Lilly (NYSE:LLY) …
Apricus Biosciences Inc (NASDAQ:APRI) investors should be smiling from ear to ear today after the biopharmaceutical company announced that Mexico has granted Apricus` commercialization partner, …
Apricus Biosciences Inc (NASDAQ:APRI) shares are set to slump following the announcement that the drug maker has received feedback in response to its previously …
